Fig. 1From: Changes in therapy and survival of metastatic renal cell carcinoma in EstoniaKaplan-Meier survival curve, mRCC patients, Estonia 2004–2012. Group 1- INFa only. Group 2- INFa followed by targeted agents or targeted agents onlyBack to article page